Please use this identifier to cite or link to this item:
Title: Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture
Authors: Azzopardi, Ernest A.
Boyce, Dean E.
Keywords: Dupuytren's contracture -- Treatment
Dupuytren's contracture -- Surgery -- Complications
Clostridium histolyticum -- Enzymology
Collagenases -- Therapeutic use
Issue Date: 2012
Publisher: Mark Allen Publishing
Citation: Azzopardi, E. A., & Boyce, D. E. (2012). Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture. British Journal of Hospital Medicine, 73(8), 432-436.
Abstract: Dupuytren’s disease is a common, costly and recurrent health issue. This review compares Clostridum histolyticumcollagenase with current operative treatments. Collagenase management is an effective non-surgical alternative associated with lower risks of serious adverse events, but higher incidence of non-serious adverse events.
Appears in Collections:Scholarly Works - FacM&SAna

Files in This Item:
File Description SizeFormat 
  Restricted Access
166.31 kBAdobe PDFView/Open Request a copy

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.